Guardant Health plans to launch a new blood-based multi-cancer test in India developed with Zydus Lifesciences. Designed for earlier detection, it can target cancers including lung, breast, and prostate. The move comes as India faces a high cancer burden alongside low routine screening rates, aiming to make screening more accessible and prompt.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
